AGENDA


Thursday, February 14th, 2008

6:15 am 6:45 am Registration/Breakfast with Exhibitors
6:45 am 7:00 am Welcome/Opening Remarks
7:00 am 7:30 am Marquis Lecture – Past, Present and Future of Coronary Intervention 

Unresolved Issues in Coronary Intervention

7:30 am 7:50 am Vascular Biology of Restenosis: Novel Strategies Directed at Prevention of Restenosis 
7:50 am 8:10 am Current Status of Bioabsorbable Stent Technology 
8:10 am 8:30 am Late Stent Thrombosis: Results of the Major Randomized Trials 
8:30 am 8:50 am Design of Future DES Clinical Trials: Safety and Effectiveness Endpoints and Follow-up Duration
8:50 am 9:20 am There is a Role for Coronary Intervention in Patients with Stable Angina – A Debate
9:20 am 9:40 am Break with Exhibitors

Cardiovascular Imaging

9:40 am 10:00 am Plaque Composition: Detection of Calcified and Non-Calcified Disease  
10:00 am 10:20 am Adult Cardiac MRI Imaging – Review of Function and Perfusion  
10:20 am 10:40 am Magnetic Guidance Applied to PCI Ultrasound
10:40 am 10:55 am Break with Exhibitors

Peripheral Vascular Disease

10:55 am 11:15 am Acute Stroke Evaluation: Diagnosis and Treatment Overview
11:15 am 11:35 am Results of Pivotal Randomized Trials in Carotid Stenting
11:35 am 11:55 am Treatment Strategies in Carotid Stenting
11:55 am 12:15 pm Complex Case Presentations in Carotids
12:15 pm 1:15 pm Lunch with Exhibitors
1:15 pm 2:15 pm Dedicated Time with Exhibitors

 

6:30 pm

 

8:00 pm

 

Poolside Reception For Faculty, Attendees and Guests


Friday, February 15th, 2008

6:45 am 7:15 am Registration/Breakfast Symposium
7:15 am 7:30 am Registration/Break with Exhibitors

AMI & ACS

7:30 am 7:50 am New “HORIZONS” in Acute MI Treatment 
7:50 am 8:10 am Emerging Pharmacologic Therapies in the Acute Ischemic Syndromes 
8:10 am 8:30 am Promising Though Not Proven Technologies in the Treatment of Acute MI
8:30 am 8:50 am Door-to-Balloon Time: The Elusive 90 Minute Target
8:50 am 9:10 am Distal Protection and Thrombectomy in Acute Intervention
9:10 am 9:25 am Break with Exhibitors

Detection of Vulnerable Plaque

9:25 am 9:45 am Defining Vulnerable Plaque  
9:45 am 10:05 am The Relevance of Vulnerable Plaque to the Clinician: Pan Coronary Instability 
10:05 am 10:25 am Utilizing Fractional Flow Reserve (FFR) for Decision-making in the Cath Lab 

Peripheral Vascular Disease II

10:25 am 10:45 am Impact of Renal Insufficiency on CAD Outcomes
10:45 am 11:00 am Break with Exhibitors
11:00 am 11:20 am Revascularization Strategies in Iliac and SFA Disease 
11:20 am 11:40 am Strategies for Limb Salvage 
11:40 am 12:00 pm Renal Artery Stenosis:  Diagnosis and Treatment Overview 
12:00 pm 12:20 pm Endovascular Treatment of Critical Limb Ischemia

WORKING LUNCH -
Unresolved Issues in Coronary Intervention: Complex PCI Subsets

12:20 pm 12:40 pm Chronic Total Occlusions 
12:40 pm 1:00 pm Bifurcation Coronary Disease 
1:00 pm 1:20 pm Left Main Disease: Is Percutaneous Intervention the Standard of Care Yet? 
1:20 pm 2:20 pm Dedicated Time with Exhibitors

 

Saturday, February 16th, 2008

8:00 am 8:30 am Breakfast

 

Patent Foramen Ovale and Atrial Appendage Therapies
8:30 am 8:50 am PFO: Embryology and Developmental Issues
8:50 am 9:10 am PFOs and Migraine Headaches: A Review of the Scientific Evidence and Clinical Association
9:10 am 9:30 am Indications for the Atrial Appendage Therapies
9:30 am 9:50 am ASD Closure
9:50 am 10:10 am Current State of the Art for Alcohol Septal Ablation

 

Unresolved Issues in Coronary Intervention: Complex PCI Subsets
10:10 am 10:30 am Balancing the Risk of Restenosis and Thrombosis: A Decision Factor for Selection of BMS vs. DES 
10:30 am 10:50 am Break
10:50 am 11:10 am Antithrombin & Antiplatelet Therapy in PCI: Recommendations for Clinical Practice
11:10 am 11:30 am PCI vs. Bypass Surgery – Current Decision Issues

 

Percutaneous Therapies in Valvular Heart Disease
11:30 am 11:50 am Most Patients with Aortic Stenosis Don’t Get Aortic Valve Replacement
11:50 am 12:10 pm Current Status of Percutaneous Aortic Valve Replacement
12:10 pm 12:30 pm Transfemoral vs. Transapical Percutaneous AV Replacement
12:30 pm 12:50 pm Percutaneous Mitral Valve Repair: The Spectrum of Leaflet Repair and Annuloplasty Devices
12:50 pm 1:00 pm Closing Statements